Cambridge Healthtech Institute’s Sixth Annual
Engineering Genes, Vectors, Constructs and Clones
PepTalk: The Protein Science Week
January 13-19, 2014

The demand for high-quality biotherapeutic proteins has never been greater. Meeting this goal of producing recombinant proteins at even higher levels requires engineering (science) and insight (art). Bottlenecks arise frequently because functional recombinant proteins are difficult to produce, and protein engineers are often forced to return to the drawing board. This usually requires designing new cloning schemes, including lengthy verification and sequence analysis of the gene or protein of interest, moving a gene from one vector to another, transfecting the vector in an alternative host, re-characterizing the expressed protein or any of the above—an inefficient, time-consuming and expensive process.

Cambridge Healthtech Institute’s Sixth Annual Engineering Genes, Vectors, Constructs and Clones meeting continues the tradition of applying effective engineering strategies for protein discovery research that leads to functional biotherapeutic products. Learn from seasoned, savvy researchers as they share their real-world experiences, applications and results.

We invite presentation proposals on the following preliminary topics:
 
 Targeting Genes

• Sequence

• Synthesis

• Selection

• Transfection

 Engineering Expression Vectors

• Viral

• Plasmid

 Prioritizing Expression Constructs

• Screening for high producers

• Screening for functional proteins

• Data analysis

Optimizing Clones

• Library construction

• Sequence verification

• Vector/host

Case Studies

• Success stories

• Best practices

• Lessons learned

Please click here to submit a speaking proposal for review.

Deadline for submission: June 7, 2013

All proposals are subject to review by the Scientific Advisory Committee to ensure the overall quality of the conference program. Please note that due to limited speaking slots, preference will be given to abstracts from those within pharmaceutical and biopharmaceutical companies, regulators and those from academic centers. Additionally, as per CHI policy, a select number of vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.

For questions about the meeting, contact: Mary Ann Brown
Executive Director, Conferences
Cambridge Healthtech Institute
Phone: 781-972-5497
Email: mabrown@healthtech.com

For partnering & sponsorship information, please contact:
Companies A-K
Jason Gerardi
Manager, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5452
Fax: 781-972-5470
Email: jgerardi@healthtech.com

Companies L-Z
Carol Dinerstein
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5471
Fax: 781-972-5470
Email: dinerstein@healthtech.com